Brief: Nhs Gives Ethical Approval For Chordate's New Migraine Study
Chordate Medical Holding publ AB CMHM.ST :
* NHS GIVES ETHICAL APPROVAL FOR CHORDATE'S NEW MIGRAINE
STUDY
* CHORDATE MEDICAL HOLDING PUBL AB - ESTIMATES THAT
SCREENING
PROCESS AT EARLIEST CAN START IN BEGINNING OF JULY 2023
Source text for Eikon: ID:nMFN6g11pZ
Further company coverage: CMHM.ST
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln